ClinicalTrials.Veeva

Menu

Rural Smoking Cessation

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Not yet enrolling

Conditions

Smoking Cessation

Treatments

Drug: Nicorette Nicotine Lozenges
Drug: Nicoderm CQ nicotine patch

Study type

Interventional

Funder types

Other

Identifiers

NCT06584929
2024LS139

Details and patient eligibility

About

Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancers and deaths. We are recruiting rural people from around the country to better understand how different quit smoking methods can improve a person's chances of successfully quitting smoking.

Full description

This is a SMART, where eligible rural people who smoke (RPWS) can be randomized up to two times to different resources/ways to help quit smoking. For each randomization, participants will use the assigned resources for 3 months, and partake in surveys at baseline, 1, and 3 months, during which they will be asked several questions related to use of resources, and smoking behavior. Carbon monoxide (CO) in exhaled breath will be collected at 3 months using iCO™ Smokerlyzer® (https://www.icoquit.com/us/) to determine biochemically confirmed abstinence.

Enrollment

272 estimated patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ≥ 21 years
  • smoke ≥ 5 cigarettes per day
  • daily access to their own iPhone/Android smartphone or tablet

Exclusion criteria

  • past 30-day NRT use or contraindications listed on the NRT labels
  • currently pregnant/breastfeeding

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

272 participants in 3 patient groups

Intervention Condition
Experimental group
Description:
Weekly text and email messages referring to Smokefree.gov, NRT Starter kit, free 2-week supply of patches (Nicoderm CQ in either 21 or 14 mg nicotine) and lozenges (Nicorette Nicotine Lozenges, Mint Flavor in either 4 or 2 mg nicotine) with NRT education plus referral to where to request more NRT.
Treatment:
Drug: Nicoderm CQ nicotine patch
Drug: Nicorette Nicotine Lozenges
Control Condition
No Intervention group
Description:
Weekly text and email messages referring to Smokefree.gov
RHE - Intervention Condition
No Intervention group
Description:
Weekly text and email messages on reduced harm or exposure (RHE) tobacco products.

Trial contacts and locations

0

Loading...

Central trial contact

Dana Carroll, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems